ST JUDE MEDICAL, LLC 4

Accession 0001179110-17-000608

CIK 0000203077operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 1:43 PM ET

Size

20.2 KB

Accession

0001179110-17-000608

Form 4

Period: 2017-01-04

Director

Transactions

Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−2,250→ 0 total
Exercise: $36.45From: 2009-11-08Exp: 2017-05-08→ Common Stock (2,250 underlying)
Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−10,000→ 0 total
Exercise: $37.15From: 2010-11-07Exp: 2018-05-07→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−9,700→ 0 total
Exercise: $52.17From: 2011-11-12Exp: 2019-05-12→ Common Stock (9,700 underlying)
Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−5,400→ 0 total
Exercise: $38.51From: 2012-11-03Exp: 2020-05-03→ Common Stock (5,400 underlying)
Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−10,000→ 0 total
Exercise: $36.45From: 2009-11-08Exp: 2017-05-08→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−600→ 0 total
Exercise: $37.15From: 2010-11-07Exp: 2018-05-07→ Common Stock (600 underlying)
Disposition to Issuer
Stock Options (Right to Buy)
2017-01-04−10,000→ 0 total
Exercise: $38.51From: 2012-11-03Exp: 2020-05-03→ Common Stock (10,000 underlying)
Disposition to Issuer
Common Stock
2017-01-04−32,863→ 0 total

Footnotes (2)

[F1]Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories ("Abbott"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the "Merger Agreement"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the "Merger Consideration"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock.
[F2]Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.

Documents

1 file

ST JUDE MEDICAL, LLC

CIK 0000203077

Entity typeoperating

IncorporatedDE